Characterisation of human cyclin G1 and G2: DNA damage inducible genes

Oncogene

Volumn 13, Issue 5, 1996, Pages 1103-1109

  Bates, Stewart ^a   Rowan, Sheldon ^a,b   Vousden, Karen H ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cyclins; DNA damage; p53

Indexed keywords

CYCLINE; DACTINOMYCIN; PROTEIN P53;

AMINO ACID SEQUENCE; ARTICLE; DNA DAMAGE; GENE INDUCTION; GENE ISOLATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE HOMOLOGY;

ACTINS; AMINO ACID SEQUENCE; BASE SEQUENCE; CLONING, MOLECULAR; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DACTINOMYCIN; DNA DAMAGE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, NUCLEIC ACID; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0029774760     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Allday MJ, Inman GJ, Crawford DH and Farrell PJ. (1995). EMBO J., 14, 4994-5005.
2. Bates S and Vousden KH. (1996). Current Opin. Genet. Dev., 6, 1-7.
3. Brugarolas J, Chandrasekaran C, Gordon JI, Beach D, Jacks T and Hannon GJ. (1995). Nature, 377, 552-556.
4. Buckbinder L, Talbott R, Velasco-Miguel S, Takenaka I, Faha B, Seizinger BR and Kley N. (1995). Nature, 377, 646-649.
5. Caellcs C, Helmberg A and Karin M. (1994). Nature. 370, 220-223.
6. Canman CE, Gilmer TM, Coutts SB and Kastan MB. (1995). Genes and Dev., 9, 600-611.
7. Crook T, Marston NJ, Sara EA and Vousden KH. (1994). Cell, 79, 817-827.
8. Deng C, Zhang P, Harper JW, Elledge SJ and Leder P. (1995). Cell, 82, 675-684.
9. Dowdy SF, Hinds PW, Louie K, Reed SI, Arnold A and Weinberg RA. (1993). Cell, 73, 499-511.
10. Dulic V, Kaufmann WK, Wilson SJ. Tlsty TD, Lees E, Harper JW, Elledge SJ and Reed SI. (1994). Cell, 76, 1013-1023.
11. El-Deiry W, Tokino T, Velculescu VE, Levy DB, Parson VE, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstcin B. (1993). Cell, 75, 817-825.
12. Ewen ME, Sluss HK, Sherr CJ, Matsunshime H, Kato J and Livingston DM. (1993). Cell, 73, 487-497.
13. Feaver WJ, Svejstrup JQ, Henry NL and Kornberg RD. (1994). Cell, 79, 1103-1109.
14. Freeman RS, Estus S and Johnson EM. (1994). Neuron, 12, 343-355.
15. Glotzer M, Murray AW and Kirschner MW. (1991). Nature, 349, 132-138.
16. Graña X and Reddy EP. (1995). Oncogene, 11, 211-219.
17. Gu Y, Turck CW and Morgan DO. (1993). Nature, 366, 707-710.
18. Guillouf C, Graña X, Selvakumaran M, Dc Luca A, Giordano A, Hoffman B and Liebermann DA. (1995). Blood, 85, 2691-2698.
19. Haffner R and Oren M. (1995). Curr. Opin. Genet. Dev., 5, 84-90.
20. Harper JW, Adami GR, Wei N, Keyomarsi K and Elledge SJ. (1993). Cell, 75, 805-816.
21. Haupt Y, Rowan S, Shalian E, Vousden KH and Oren M. (1995). Genes and Dev., 9, 2170-2183.
22. Houng AT, Cohen KJ, Barrett JF, Bergstrom DA and Chang CV. (1994). Proc. Natl. Acad. Sci. USA, 91, 6875-6879.
23. Kato J, Matsushime H, Hiebert SW, Ewen ME and Sherr CJ. (1993). Genes & Development, 7, 331-342.
24. Hessis TD, Slebos RJ, Nelson WG, Kastan MB, Plunkett BS, Man SM, Lorincz AT, Hedrick L and Cho KR. (1993). Proc. Natl. Acad. Sci. USA, 90, 3988-3992.
25. Knudson MC, Tung KSK, Tourtelotte WG, Brown GAJ and Korsmeyer SJ. (1995). Science, 270, 96-98.
26. Kobayashi T, Consoli U, Andreeff M, Shiku H, Deisseroth AB and Zhang W. (1995). Oncogene, 11, 2311-2316.
27. Kranenburg O, van der Eb A and Zantema A. (1996). EMBO J., 15, 46-54.
28. Lew DJ, Dulic V and Reed SI. (1991). Cell, 66, 1191-1206.
29. Meikrantz W, Gisselbrecht S, Tam SW and Schlegel R. (1994). Proc. Natl. Acad. Sci. USA, 91, 3754-3758.
30. Miyashita T, Krajewski S, Krajewski M, Wang HG, Lin HK, Liebermann DA, Hoffman B and Reed JC. (1994). Oncogene, 9, 1799-1805.
31. Miyashita T and Reed JC. (1995). Cell. 80, 293-299.
32. Nakamura T, Sanokawa R, Sasaki YF, Ayusawa D, Oishi M and Mori N. (1995). Exp. Cell Res., 21, 534-542.
33. Nurse P. (1994). Cell, 79, 547-550.
34. Okamoto K and Beach D. (1994). EMBO J., 13, 4816-4822.
35. Oltvai ZN, Milliman CL and Korsmeyer SJ. (1993). Cell, 74, 609-619.
36. Pietenpol JA, Tokino T, Thiagaligam S, El-Deiry W, Kinzler KW and Vogelstein B. (1994). Proc. Natl. Acad. Sci. USA, 91, 1998-2002.
37. Poon RYC, Yamashita K, Howell M, Ershler MA, Belyavsky A and Hunt T. (1994). J. Cell Sci., 107, 2789-2799.
38. Rogers S, Wells R and Rechsteiner M. (1986). Science, 234, 364-368.
39. Rowan S, Ludwig RL, Haupt Y, Bates S, Lu X, Oren M and Vousden KH. (1996). EMBO J., 15, 827-838.
40. Roy R, Adamczewski JP, Seroz T, Vermeulen W, Tassan JP, Schaeffer L, Nigg EA, Hoeijmakers JHJ and Egly JM. (1994). Cell, 79, 1093-1101.
41. Sabbatini P, Lin J, Levine AJ and White E. (1995). Genes and Dev., 9, 2184-2192.
42. Sherr CJ. (1993). Cell, 73, 1059-1065.
43. Soloman MJ, (1994). Trends in Biochemical Sciences. 19, 496-500.
44. Tamura K, Kanaoka Y, Jinno S, Nagata A, Ogiso Y, Shimizu K, Hayakawa T, Nojima H and Okayama H. (1993). Oncogene, 8, 2113-2118.
45. Tassan J-P, Jaquenoud M, Léopold P, Schultz SJ and Nigg EA. (1995). Proc. Natl. Acad. Sci. USA, 92, 8871-8875.
46. Vojtesek B, Bartek J, Midgley CA and Lane DP. (1992). J. of Immunol. Meth., 151, 237-244.
47. Waldman T, Kinzler KW and Vogelstein B. (1995). Cancer Res., 55, 5187-5190.
48. Wu L, Liu L, Yee A, Carbonaro-Hall D, Tolo VT and Hall F. (1994). Oncol. Rep., 1, 705-711.
49. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R and Beach D. (1993). Nature, 366, 701-704.
50. Yonish-Rouach E, Deguin V, Zaitchouk T, Breugnot C, Mishal Z, Jenkins JR and May E. (1996). Oncogene, 12, 2197-2205.
51. Zaubermann A, Lupo A and Oren M. (1995). Oncogene, 10, 2361-2366.
52. Zhan Q, Fan S, Bae I, Guillouf C, Liebermann DA, O'Connor PM and Fornace JAJ. (1994). Oncogene, 9, 3743-3751.